Home Tags SMAC-Technology

Tag: SMAC-Technology

Featured Image: Laboratory Glass works. Courtesy: © 2010 - 2018. Fotolia Used with permission.

Steffen Heeger, MD, Ph.D to Lead NBE-Therapeutics’ Clinical iADC Development

Privately-owned Swiss, Basel-based, NBE-Therapeutics has appointed Steffen Heeger MD, Ph.D. as Chief Medical Officer to lead the clinical development of NBE-002, the company's first...

WuXi Biologics and NBE-Therapeutics Collaborate in Development and Manufacturing Partnership

WuXi Biologics, an open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Swiss biotech NBE-Therapeutics, developing best-in-class, next-generation...

NBE Therapeutics Receives Additional Series B Financing – Supports Clinical Testing...

Novo Holdings, a Danish private limited liability company wholly owned by the Novo Nordisk Foundation, manages the Foundation's investment assets. Earlier this year, the...

PepTalk 2017: Antibody-drug Conjugates and the Promise of Innovation

ADC or antibody-drug conjugates have recently been at the forefront of cancer research, and according to the experts presenting their latest data during the...

FEATURED RESOURCES